セレイドセラピューティクス株式会社

Celaid Therapeutics specializes in manufacturing and sales of regenerative medicine products utilizing human hematopoietic stem cells.

セレイドセラピューティクス株式会社 operates in health based in Tokyo, Japan.

Profile

"Celaid Therapeutics is a leading medtech company specializing in regenerative medicine products derived from human hematopoietic stem cells. With a focus on developing innovative cell therapy treatments for blood cancers and genetic disorders, Celaid Therapeutics is at the forefront of the global regenerative medicine and drug discovery research landscape. By leveraging platform technologies and advancing clinical development, Celaid Therapeutics aims to revolutionize the field of regenerative medicine and contribute to the development of novel therapies for leukemia and other hematologic malignancies. The company's commitment to technological innovation and clinical advancement underscores its dedication to pioneering new treatment options and supporting the evolution of regenerative medicine on a global scale."

The company sits in the health segment, where it competes on its core product or service.

Tokyo, Japan is where the company is located.

Its current recorded stage is Plug and Play portfolio startup.

Website: celaidtx.com